Lyra Therapeutics LYRA
LYRA
$0.20 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Lyra Therapeutics (LYRA) Shares Outstanding (Entity) (2019 - 2025)

Updated

Lyra Therapeutics' Shares Outstanding (Entity) came in at 1.77 million for Q4 2025, up 35.5% from 1.31 million a year earlier and up 7.9% from the prior quarter.

Analysis

Lyra Therapeutics (LYRA) Shares Outstanding (Entity) (2019 - 2025) Analysis & Trends

Going back to Q1 2019, Lyra Therapeutics' Shares Outstanding (Entity) data covers 28 quarters.

  • Shares Outstanding (Entity) has increased in each of the last five years, with a five-year compound annual growth rate of 59.5% (FY2020 to FY2025).
  • Going back by year, Shares Outstanding (Entity) was 1.31 million in FY2024 (+14.5%), 1.14 million in FY2023 (+79.8%), 636,553 in FY2022 (+144.7%) and 260,144 in FY2021 (+51.4%).
  • The Q4 2025 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2019.
  • Year-over-year, Shares Outstanding (Entity) has increased for 19 consecutive quarters, with growth averaging 30.3% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 0.4% (Q1 2022) to 144.8% (Q2 2022).
  • Business Quant data shows LYRA's Shares Outstanding (Entity) at 1.64 million (Q3 2025), 1.35 million (Q2 2025) and 1.32 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Lyra Therapeutics 354,976.41 354,976.41 - 1.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.77 Mn
Sep 30, 2025 1.64 Mn
Jun 30, 2025 1.35 Mn
Mar 31, 2025 1.32 Mn
Dec 31, 2024 1.31 Mn
Sep 30, 2024 1.31 Mn
Jun 30, 2024 1.31 Mn
Mar 31, 2024 1.22 Mn
Dec 31, 2023 1.14 Mn
Sep 30, 2023 990,911.00
Jun 30, 2023 990,901.00
Mar 31, 2023 636,736.00
Dec 31, 2022 636,553.00
Sep 30, 2022 636,540.00
Jun 30, 2022 636,527.00
Mar 31, 2022 260,198.00
Dec 31, 2021 260,144.00
Sep 30, 2021 260,092.00
Jun 30, 2021 260,022.00
Mar 31, 2021 259,255.00
API Access

Lyra Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=LYRA&period=max&api_key=YOUR_API_KEY